Related Experiment Video
Updated: Aug 17, 2025
12:50
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
6.6K
Growth Hormone-Releasing Hormone in Endothelial Inflammation.
Nektarios Barabutis1, Mohammad S Akhter1, Khadeja-Tul Kubra1
1School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, USA.
Endocrinology
|December 12, 2022
Summary
Growth hormone-releasing hormone (GHRH) antagonists show protective effects against vascular dysfunction. These findings suggest potential new therapies for inflammatory and vascular remodeling diseases like sepsis and ARDS.
Area of Science:
- Endocrinology
- Vascular Biology
- Pharmacology
Background:
- Hypothalamic hormones, including Growth hormone-releasing hormone (GHRH), are vital for homeostasis and growth hormone regulation.
- Emerging evidence indicates GHRH's potential role in promoting inflammation and malignancies.
- Current targeted therapies for vascular remodeling pathologies remain limited.
Approach:
- This review synthesizes recent findings on the role of GHRH and its antagonists in inflammation and vascular function.
- Focuses on preclinical studies investigating the impact of GHRH antagonists on endothelial barrier integrity.
- Summarizes the therapeutic potential of GHRH antagonists in vascular-related diseases.
Key Points:
- GHRH antagonists demonstrate a protective effect against endothelial barrier dysfunction in preclinical models.
- The 44-amino acid peptide GHRH and its antagonists are implicated in inflammatory processes.
- GHRH antagonists may offer novel therapeutic strategies for conditions involving vascular remodeling.
Conclusions:
- GHRH antagonists represent a promising avenue for developing treatments for sepsis and acute respiratory distress syndrome.
- Further research into GHRH antagonists could lead to breakthroughs in managing inflammatory and vascular diseases.
- The therapeutic potential of GHRH antagonists warrants continued investigation for various pathologies.
More Related Videos
08:46Strategic Endothelial Cell Tube Formation Assay: Comparing Extracellular Matrix and Growth Factor Reduced Extracellular Matrix
Published on: August 14, 2016
13.6K
09:03Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
Published on: June 30, 2023
1.1K
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
01:28Role of Hematopoietic Growth Factors
1.5K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.5K
01:10Mechanism of Angiogenesis
5.7K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.7K
01:17Hormones and Bone Tissue
2.8K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.8K
01:21Paracrine Signaling
55.3K
Paracrine signaling allows cells to communicate with their immediate neighbors via secretion of signaling molecules. Such a signal can only trigger a response in nearby target cells because the signal molecules degrade quickly or are inactivated if not taken up. Prominent examples of paracrine signaling include nitric oxide signaling in blood vessels, synaptic signaling of neurons, the blood clotting system, tissue repair/wound healing, and local allergic skin reactions. Nitric oxide as a...
55.3K
01:16Hormones Regulating Blood Glucose
3.7K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.7K